111 related articles for article (PubMed ID: 903183)
1. Sequential evaluation of cutaneous delayed hypersensitivity responses to recall and to lymphoid cell line antigens in Burkitt's lymphoma.
Nkrumah FK; Herberman R; Biggar R; Perkins IV
Int J Cancer; 1977 Jul; 20(1):6-11. PubMed ID: 903183
[TBL] [Abstract][Full Text] [Related]
2. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous reactivity to the so-called "recall" antigens in 4 patients with Burkitt's African lymphoma].
Jirillo E; Frugis Caggianelli L; De Rinaldis P; Fumarola D
Pathologica; 1976; 68(979-980):247-52. PubMed ID: 1018982
[No Abstract] [Full Text] [Related]
4. Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: alterations induced by a tumour burden and by BCG administration.
Magrath IT
Int J Cancer; 1974 Jun; 13(6):839-49. PubMed ID: 4604572
[No Abstract] [Full Text] [Related]
5. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
[TBL] [Abstract][Full Text] [Related]
6. Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines.
Levine PH; Ho JH; Nkrumah F; Periman P; Mourali N; Cannon G; Middleton MB; Perkins IV; Herberman R
Int J Cancer; 1978 Oct; 22(4):400-4. PubMed ID: 81188
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin A receptors on the surface membrane of lymphocytes from patients with African Burkitt's lymphoma and lymphoma cell lines.
Ben-Bassat H; Goldblum N; Mitrani S; Klein G; Johansson B
Int J Cancer; 1976 Apr; 17(4):448-54. PubMed ID: 1279037
[TBL] [Abstract][Full Text] [Related]
8. Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.
Fass L; Herberman RB; Ziegler J
N Engl J Med; 1970 Apr; 282(14):776-80. PubMed ID: 5416971
[No Abstract] [Full Text] [Related]
9. Burkitt's tumor in the United States.
Cohen MH; Bennett JM; Berard CW; Ziegler JL; Vogel CL; Sheagren JN; Carbone PP
Cancer; 1969 Jun; 23(6):1259-72. PubMed ID: 5771062
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Gunvén P; Klein G; Clifford P; Singh S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
Levine PH; Ho JH; Nkrumah F; Andrese AP
IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
[No Abstract] [Full Text] [Related]
12. Immunologic studies in Burkitt's lymphoma.
Ziegler JL; Cohen MH; Morrow RH; Kyalwazi SK; Carbone PP
Cancer; 1970 Mar; 25(3):734-9. PubMed ID: 4984654
[No Abstract] [Full Text] [Related]
13. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
15. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Burdick JF; Wells SA; Herberman RB
Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
[TBL] [Abstract][Full Text] [Related]
16. Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.
Weliky N; Leaman DH; Kallman BJ
J Natl Cancer Inst; 1975 Mar; 54(3):593-6. PubMed ID: 164559
[TBL] [Abstract][Full Text] [Related]
17. Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study.
Bluming AZ; Ziegler JL; Fass L; Herberman RB
Clin Exp Immunol; 1971 Dec; 9(6):713-9. PubMed ID: 5158270
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA
Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015
[TBL] [Abstract][Full Text] [Related]
19. A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
Lapalombella R; Zhao X; Triantafillou G; Yu B; Jin Y; Lozanski G; Cheney C; Heerema N; Jarjoura D; Lehman A; Lee LJ; Marcucci G; Lee RJ; Caligiuri MA; Muthusamy N; Byrd JC
Clin Cancer Res; 2008 Jan; 14(2):569-78. PubMed ID: 18223233
[TBL] [Abstract][Full Text] [Related]
20. Ouabain induces apoptosis and autophagy in Burkitt's lymphoma Raji cells.
Meng L; Wen Y; Zhou M; Li J; Wang T; Xu P; Ouyang J
Biomed Pharmacother; 2016 Dec; 84():1841-1848. PubMed ID: 27894666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
